Leflunomide is a disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis and psoriatic arthritis. It inhibits dihydroorotate dehydrogenase, a key enzyme in pyrimidine synthesis, thereby suppressing the proliferation of activated lymphocytes. Leflunomide helps reduce joint inflammation and progression of structural damage. It may cause liver toxicity, so liver function monitoring is essential.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Leminoprazole and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Leminoprazole impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Leminoprazole-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
